Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.
about
Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressantsPreclinical evidence of rapid-onset antidepressant-like effect in Radix Polygalae extractKetamine and other glutamate receptor modulators for depression in adultsA Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorderThe neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulationRapid antidepressant effects: moving right alongmTOR activation is required for the antidepressant effects of mGluR₂/₃ blockadeReplication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trialA randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depressionTowards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disordersThe molecular neurobiology of depressionStress as a one-armed bandit: Differential effects of stress paradigms on the morphology, neurochemistry and behavior in the rodent amygdala.Potential of Glutamate-Based Drug Discovery for Next Generation AntidepressantsChallenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved TherapeuticsAntidepressant mechanism of ketamine: perspective from preclinical studiesGlial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?Review of pharmacological treatment in mood disorders and future directions for drug development.Antidepressant actions of ketamine: from molecular mechanisms to clinical practiceA conceptual and practical guide to the behavioural evaluation of animal models of the symptomatology and therapy of schizophrenia.Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to dateKetamine for treatment-resistant unipolar depression: current evidenceKetamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacyRapid Antidepressant Action and Restoration of Excitatory Synaptic Strength After Chronic Stress by Negative Modulators of Alpha5-Containing GABAA Receptors.Regulation of fear extinction versus other affective behaviors by discrete cortical scaffolding complexes associated with NR2B and PKA signalingCurrent investigational drugs for major depressionR-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effectsSubanesthetic dose of ketamine decreases prefrontal theta cordance in healthy volunteers: implications for antidepressant effectChronic stress induces a selective decrease in AMPA receptor-mediated synaptic excitation at hippocampal temporoammonic-CA1 synapsesDual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugsKetamine influences CLOCK:BMAL1 function leading to altered circadian gene expressionKetamine decreases resting state functional network connectivity in healthy subjects: implications for antidepressant drug actionImpact of ketamine on learning and memory function, neuronal apoptosis and its potential association with miR-214 and PTEN in adolescent ratsStress-induced changes of hippocampal NMDA receptors: modulation by duloxetine treatmentA Clickable Analogue of Ketamine Retains NMDA Receptor Activity, Psychoactivity, and Accumulates in Neurons.Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor antagonist propertiesmTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonistsObservation of Distressed Conspecific as a Model of Emotional Trauma Generates Silent Synapses in the Prefrontal-Amygdala Pathway and Enhances Fear Learning, but Ketamine Abolishes those EffectsA Negative Allosteric Modulator for α5 Subunit-Containing GABA Receptors Exerts a Rapid and Persistent Antidepressant-Like Action without the Side Effects of the NMDA Receptor Antagonist Ketamine in Mice.NMDAR inhibition-independent antidepressant actions of ketamine metabolites.The Prodrug 4-Chlorokynurenine Causes Ketamine-Like Antidepressant Effects, but Not Side Effects, by NMDA/GlycineB-Site Inhibition.
P2860
Q21129276-277ABD3B-BAE4-4211-9232-AF7FE97B7A6AQ21132322-291FA09E-9683-4667-B2D3-D9596C7DD922Q24186746-C9E79658-03A7-4B02-9993-BD82E1FC608DQ24602988-0A95735F-AE59-48ED-8D8C-936BF9B7580FQ24613593-FC59458D-CA25-49D4-B8AC-DCA344F6345BQ24614410-44D8D663-1AE6-48B7-94D1-23044A076D26Q24617166-4CD1B23D-71BC-4A90-AD2C-15E1F1460EEEQ24629398-2D64D559-9B2A-4489-A75E-6C6F4D4D973DQ24630153-C264316E-45D0-4FC6-AE85-060C2E995757Q24632936-750661A4-2A8E-47C1-A1E5-39D23445CCC7Q24656261-432C3C55-30CD-49B0-88D6-97493B4B465FQ26769043-030ABD09-86F0-44EF-A5A4-5C37EEFE4CBEQ26782274-FEDBBD01-1117-4754-9CCC-69E288B84108Q26782997-3B91770E-7F74-4F12-A218-746F9705D8C2Q26800231-275BA706-55D2-4827-93D2-710EE6FC1A3EQ26829556-0E9290E3-3173-4BAF-A046-FA231779BA7BQ26853509-FAB45B3B-81A5-4AB3-9269-772F50F08C7CQ26995879-D3A637AE-D0C6-4085-ADC3-50AC84274925Q27001119-7E2339D6-DF64-4868-A9F6-6A34B16E6F26Q27004490-27B42440-133F-4222-90B9-0EC600BFF100Q27004508-32232CAB-481D-427F-945C-2816A48F78B4Q27024227-D52410D3-624E-4059-B579-C9D11EAA07F1Q27310950-E16B57C2-2534-4AAE-B07E-62CA37BE31ACQ27339589-EA877A54-0E8A-4A5D-AF95-2DC3558C2F67Q28244223-27D535BD-64FF-42B8-81F4-FBBA18672199Q28266846-EA61137B-0342-4F7D-B58D-48981093B39DQ28267032-8FED2D79-5BD7-4BEC-8F25-FC447796AE7CQ28299724-B7433824-E40F-45A3-8052-B18525B23215Q28305100-CA2CE86D-1096-419D-AB52-4F19907C2C41Q28476686-4E0F3DA6-5739-4F78-B894-5ACB22415417Q28484157-C758B0DE-B3C5-4D9C-B750-40CA6E6F042BQ28539562-8CF1ABA1-BC7D-4AB2-9F7C-3256DC06B756Q28729135-DD06C010-92D1-4ED1-821E-B82E03810B84Q28817259-F50690DA-2860-49DE-A21C-5B4FC82F197CQ28820763-AF7C5B4E-336C-4C8A-B7E3-BBE0F8BD2E99Q29618120-9782C93B-7EB7-4BE9-AFDB-2756BC6B2C7CQ30300197-08E3FC87-BE4B-4893-80AB-52E2B311040AQ30361531-CB2F9067-035E-4C35-98B1-C25685370837Q30370600-0A0F7E94-0023-45D9-A73F-FCC6150DC183Q30373328-ACF06084-F51D-43C2-BA3F-88DF07CCE820
P2860
Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Cellular mechanisms underlying ...... le-4-propionic acid receptors.
@en
Cellular mechanisms underlying ...... le-4-propionic acid receptors.
@nl
type
label
Cellular mechanisms underlying ...... le-4-propionic acid receptors.
@en
Cellular mechanisms underlying ...... le-4-propionic acid receptors.
@nl
prefLabel
Cellular mechanisms underlying ...... le-4-propionic acid receptors.
@en
Cellular mechanisms underlying ...... le-4-propionic acid receptors.
@nl
P2093
P1476
Cellular mechanisms underlying ...... le-4-propionic acid receptors.
@en
P2093
Carlos A Zarate
Guang Chen
Husseini K Manji
Joseph McCammon
Robert J Schloesser
Sungho Maeng
P304
P356
10.1016/J.BIOPSYCH.2007.05.028
P407
P577
2007-07-23T00:00:00Z